- Home
- AMLX vs NBR Comparison
AMLX vs NBR Comparison
Compare AMLX & NBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AMLX | NBR |
|---|---|---|
| Founded | 2014 | 1952 |
| Country | United States | Bermuda |
| Employees | N/A | 13900 |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | AMLX | NBR |
|---|---|---|
| Price | $14.54 | $102.12 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 7 |
| Target Price | $21.56 | ★ $75.00 |
| AVG Volume (30 Days) | ★ 1.1M | 247.8K |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 65.46 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $380,786,000.00 | N/A |
| Revenue This Year | N/A | $3.65 |
| Revenue Next Year | N/A | $4.88 |
| P/E Ratio | ★ N/A | $4.33 |
| Revenue Growth | ★ 1612.94 | N/A |
| 52 Week Low | $4.86 | $27.33 |
| 52 Week High | $18.61 | $112.90 |
Technical Indicators
Market Signals| Indicator | AMLX | NBR |
|---|---|---|
| Relative Strength Index (RSI) | 53.00 | 55.20 |
| Support Level | $12.32 | $92.66 |
| Resistance Level | $15.37 | $105.80 |
| Average True Range (ATR) | 0.79 | 4.99 |
| MACD | 0.13 | 0.03 |
| Stochastic Oscillator | 81.78 | 69.23 |
Price Performance
Historical ComparisonAbout AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.
About NBR Nabors Industries Ltd.
Nabors Industries Ltd owns and operates land-based drilling rig fleets and is a provider of offshore platform rigs in the United States and international markets. It also provides performance tools, directional drilling services, tubular running services, and technologies. The company has four reportable segments: U.S. Drilling, International Drilling, Drilling Solutions, and Rig Technologies. The key revenue of the company is generated from International Drilling.